Virtual Library

WS01.01 - Session Introduction

09:00 - 09:10  |  Author(s): Alex Adjei

WS01.02 - Technical Aspects of Editorial Manager

09:10 - 09:25  |  Author(s): Mary Todd

WS01.04 - Abstract, Introduction

09:40 - 09:55  |  Author(s): ENRIQUETA FELIP

WS01.06 - Methods

10:05 - 10:20  |  Author(s): Anne-Marie Baird

WS01.10 - Participant Presentation: Article 3 Review by Haval Balata, Jules Derks, Francesca Jacobs, Laura Moliner, Filiz Oezkan

11:00 - 11:25

WS01.13 - Article 2 Summary + Group Discussion

13:20 - 13:50  |  Author(s): Anne-Marie Baird

WS01.16 - Article 1 Summary + Group Discussion

14:30 - 15:00  |  Author(s): ENRIQUETA FELIP

WS01.17 - Further Q&A

15:00 - 15:15

WS02.02 - Session Introduction

09:02 - 09:04  |  Author(s): David Baldwin

WS02.08 - Session 1 Welcome

09:13 - 09:15  |  Author(s): Stephen Lam

WS02.09 - Key Elements for Successful Implementation of a National Screening Program - The Taiwan Experience

09:15 - 09:25  |  Author(s): Pan Chyr Yang

WS02.10 - LungPlan (Financial Modeling to Secure Resources for Lung Screening and Nodule Management Program)

09:25 - 09:35  |  Author(s): Ella A Kazerooni

WS02.11 - LungPlan (Financial Modeling to Secure Resources for Lung Screening and Nodule Management Program)

09:35 - 09:45  |  Author(s): Robert Smith

WS02.12 - Optimal Smoking Cessation Strategy

09:45 - 09:55  |  Author(s): Matthew Peters

WS02.13 - Panel Discussion & Live Q&A

09:55 - 10:25

WS02.15 - Session 2 Welcome

10:40 - 10:43  |  Author(s): David Baldwin

WS02.17 - Training, Assessment and Standardized Cad-Based Reporting - The British Columbia Lung Screening Program

10:45 - 10:55  |  Author(s): Stephen Lam

WS02.18 - IASLC Education Resource Initiative

10:55 - 11:05  |  Author(s): Natthaya Triphuridet

WS02.19 - Quality Assurance of Radiology Reporting: PERFECTS

11:05 - 11:15  |  Author(s): Yan Chen

WS02.20 - CAD/AI in Screening Interpretation: From Detection through Management

11:15 - 11:25  |  Author(s): Matthijs Oudkerk

WS02.21 - Panel Discussion & Live Q&A

11:25 - 11:55

WS02.24 - Welcome Back/Q&A from Morning Sessions

13:03 - 13:10  |  Author(s): Harry J de Koning

WS02.25 - Assessing Lung Cancer Risk from a Single Chest CT

13:10 - 13:20  |  Author(s): Marjolein Heuvelmans

WS02.26 - Personalized Risk Assessment Using Blood and Imaging Biomarkers

13:20 - 13:30  |  Author(s): Hilary A Robbins

WS02.27 - Deep Learning Approach to Optimize the Lung Cancer Screening Interval

13:30 - 13:40  |  Author(s): Ping Hu

WS02.28 - Future Directions Using AI Technologies for Early Lung Cancer Detection

13:40 - 13:50  |  Author(s): Georg Langs

WS02.29 - Panel Discussion & Live Q&A

13:50 - 14:20

WS02.31 - Session 4 Welcome

14:30 - 14:33  |  Author(s): Ella A Kazerooni

WS02.34 - Incidental Lung Nodules - An Opportunity to Advance Early Lung Cancer Detection

14:45 - 14:55  |  Author(s): Raymond U Osarogiagbon

WS02.35 - Benchmarks for Diagnostic Workup of Early Lung Cancer

14:55 - 15:05  |  Author(s): Annette Maree McWilliams

WS02.36 - Additional Findings in Lung Cancer Screening

15:05 - 15:15  |  Author(s): David Baldwin

WS02.37 - Panel Discussion & Live Q&A

15:15 - 15:40

WS02.38 - Workshop Summary/Conclusion

15:40 - 15:50  |  Author(s): John K Field

WS03.03 - Introduction to the IASLC - Why You Should Be a Member

08:06 - 08:21  |  Author(s): Karen Kelly

WS03.04 - Making the Most of WCLC: A Guide for First Time Attendees

08:21 - 08:36  |  Author(s): Jarushka Naidoo

WS03.05 - Planning a Career in Lung Cancer - Bench to Bedside and Educational

08:36 - 08:51  |  Author(s): Anne-Marie Dingemans

WS03.06 - Planning a Career in Lung Cancer - Sponsored and Academic Trials

08:51 - 09:06  |  Author(s): Ross Soo

WS03.07 - Planning a Career in Lung Cancer - A New Era of Trial Designs

09:06 - 09:21  |  Author(s): Simon Ekman

WS03.09 - Principles to Get Your Paper Published

09:51 - 10:06  |  Author(s): Alex Adjei

WS03.10 - How to Give a Great Presentation

10:06 - 10:21  |  Author(s): Pasi A Janne

WS03.11 - Role of IASLC in Developing Countries

10:21 - 10:36  |  Author(s): Clarissa Mathias

WS03.12 - Early Career Researcher Experience

10:36 - 10:51  |  Author(s): Alessandro Russo

WS03.13 - Live Q&A

10:51 - 11:30

WS04.01 - Session Introduction

08:00 - 08:03  |  Author(s): Kenneth John O'Byrne

WS04.02 - Session Introduction

08:03 - 08:05  |  Author(s): Arnaud Scherpereel

WS04.04 - Personalizing Immunotherapy

08:20 - 08:40  |  Author(s): Ibiayi Dagogo-Jack

WS04.06 - Live Q&A

08:50 - 09:00

WS04.07 - Biology

09:00 - 09:30  |  Author(s): Yoshitaka Sekido

WS04.09 - Pathology

09:30 - 09:45  |  Author(s): Francoise Blanche Galateau Salle

WS04.10 - Live Q&A

09:45 - 09:55

WS04.14 - Panel - Everything You Wanted to Know About Mesothelioma but Were Afraid to Ask

11:00 - 11:00  |  Author(s): Arnaud Scherpereel

WS05.01 - Introduction & Live Tweeting Session

09:00 - 09:03  |  Author(s): Brendon Stiles

WS05.04 - Building a Personal Brand on Social Media

09:10 - 09:15  |  Author(s): Stephen V. Liu

WS05.05 - Promoting Your Research through Traditional and Social Media Networks

09:15 - 09:20  |  Author(s): Matthew Smeltzer

WS05.06 - Engaging in Latin America

09:20 - 09:25  |  Author(s): Jose Francisco Corona-Cruz

WS05.08 - How to Give the Perfect Interview (Traditional Approach to Media/Trade Interviews)

09:30 - 09:35  |  Author(s): Karen Reckamp

WS05.09 - Using Podcast to Promote Your Message and Disseminate Research

09:35 - 09:40  |  Author(s): Narjust Florez (Duma)

WS06.01 - ITONF AGM - ITONF Membership

12:00 - 12:30  |  Author(s): Mary Duffy

WS06.03 - Welcome

13:00 - 13:05  |  Author(s): Mary Duffy

WS06.04 - Welcome

13:05 - 13:10  |  Author(s): Maria Ftanou

WS06.06 - Targeted Therapy in NSCLC - New Frontiers

13:15 - 13:30  |  Author(s): Marianne Davies

WS06.07 - Beyond Treating the Disease, Addressing the Person We Care For - Symptom Management, Palliative Care, Survivorship

13:30 - 13:45  |  Author(s): Polly H Dufton

WS06.08 - Unlocking the Secrets of Immunotherapy - What Clinicians Need to Know

13:45 - 14:00  |  Author(s): Michelle M Turner

WS06.09 - Live Q&A

14:00 - 14:10

WS06.12 - Stigma & Shame Still an Issue in Lung Cancer?

14:35 - 14:50  |  Author(s): Maria Ftanou

WS06.13 - Enhancing Health Literacy Amongst Care Givers of People with Lung Cancer

14:50 - 15:05  |  Author(s): Simon Dunne

WS06.14 - Supporting Children of Parents & Grandparents with Lung Cancer

15:05 - 15:20  |  Author(s): Elena Schiena

WS06.15 - Live Q&A

15:20 - 15:30

WS06.18 - Working across Borders, Egypt & ITONF’s Educational Modules

15:55 - 16:10  |  Author(s): Mary Duffy

WS06.19 - Clinician Professional & Academic Development - From Bedside to Bench: Getting Involved in Research - A Practical Approach

16:10 - 16:20  |  Author(s): Morten Quist

WS06.20 - Clinician Professional & Academic Development - From Bedside to Bench: The Grant Application Process

16:20 - 16:30  |  Author(s): Jacqui Frowen

WS06.21 - Clinician Professional & Academic Development - From Bedside to Bench: Getting Published

16:30 - 16:40

WS06.22 - Clinician Professional & Academic Development - From Bedside to Bench: Getting Involved in Clinical Practice Guidelines Development

16:40 - 16:50  |  Author(s): Marianne Davies

WS06.23 - Successfully Navigating the WCLC2022 Program Summary & Close

16:50 - 17:00  |  Author(s): Morten Quist

WS07.03 - Effect of Mirtazapine on Energy Intake in Patients with Anorexia Associated with NSCLC

15:02 - 15:12  |  Author(s): Oscar Arrieta

WS07.04 - KRAS Alterations, Clinicopathological Features and Co-occurring Drivers Associated with Prognosis in Advanced NSCLC Patients

15:12 - 15:22  |  Author(s): Maritza Ramos-Ramirez

WS07.06 - Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression

15:32 - 15:42  |  Author(s): Pedro Aguiar Jr

WS07.07 - Discussant

15:42 - 15:52  |  Author(s): Andres F Cardona

WS07.08 - Ancestry and Somatic Mutations in Lung Cancer in Latin America

15:52 - 16:02  |  Author(s): Ticiana Leal

WS07.09 - Challenges of Implementing Lung Cancer Screening in Latin Countries

16:02 - 16:12  |  Author(s): Ricardo Sales Santos

WS07.10 - Lung Cancer Disparities in Molecular Testing and Therapy Outcome in Hispanics in LATAM

16:12 - 16:22  |  Author(s): Luis Raez, MD, FACP, FCCP

WS07.11 - Live Q&A

16:22 - 16:30

PL01.01 - Welcome and Introduction

Session Moderator

Session Moderator

Session Moderator

Session Moderator

Session Moderator

Session Moderator

Session Moderator

Session Moderator

PL01.02 - Welcome and Introduction

PL01.03 - Welcome and Introduction

PL01.04 - Welcome and Introduction

PL01.05 - Welcome and Introduction

PL01.06 - Welcome Address - IASLC President

PL01.07 - Welcome Address - IASLC Past President

PL01.08 - Welcome Address - IASLC CEO

PL01.09 - IASLC Distinguished Service Award Presentations

PL01.11 - Immune Checkpoint Inhibitors

PL01.10 - “We’ll Do the Best We Can for as Long as We Can” and Other Assumptions I Hope We’ll Make Obsolete in My Lifetime

PL01.12 - mRNA Vaccines for Prevention or Treatment of Disease

WS08.05 - Minimal Residual Disease (MRD) Negative: Potential for Cure in Resected Oncogene Driven NSCLC? Chinese Perspective

21:10 - 21:30  |  Author(s): Jia-Tao Zhang

WS08.06 - Could MRD Change Our Clinical Practice? North American Perspective

21:30 - 21:50  |  Author(s): Aadel Chaudhuri

WS08.07 - How to Use Liquid Biopsy to Monitor Treatment Efficacy for Advanced Driven NSCLC

21:50 - 22:10  |  Author(s): Jie Hu

WS08.09 - Sintilimab versus Pembrolizumab as Monotherapy or in Combination with Chemotherapy for Treatment Naïve Metastatic Non-small Cell Lung Cancer

22:30 - 22:40  |  Author(s): Si-Yang Maggie Liu

WS08.10 - Toripalimab in Combination with CIK Cells in Patients with Advanced NSCLC: An Exploratory Study

22:40 - 22:50  |  Author(s): Baohui Han

WS08.13 - Activity of aPD1-MSLN-CART Cells Against Metastatic Lung Cancer in a Phase 1 Trial

23:20 - 23:21  |  Author(s): Lingjuan Chen

WS08.14 - Final Analyses of ALTER-L018: A Randomized Phase II Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-line Therapy for EGFR-Negative NSCLC

23:21 - 23:22  |  Author(s): Lin Wu

WS08.15 - Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC

23:22 - 23:23  |  Author(s): Jun Zhao

WS08.16 - The Increase of Blood Intratumor Heterogeneity is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC

23:23 - 23:24  |  Author(s): Juan Zhou

WS08.17 - Utilization of Tumor Mutational Profiling to Identify the Immunotherapy Response in Non-small Cell Lung Cancer

23:24 - 23:25  |  Author(s): Peng Song

WS08.18 - Discussant for Poster 1 - 5

23:25 - 23:40  |  Author(s): Xiaorong Dong

WS08.24 - Discussant for Poster 6 - 10

23:35 - 23:50  |  Author(s): Ming Fang Zhao

WS08.19 - Phase Il Trial of Neoadjuvant Tislelizumab with Chemotherapy for Resectable Stage IIB-III Non-small Cell Lung Cancer

23:40 - 23:41  |  Author(s): Yao-Bin Lin

WS08.20 - Comprehensive Analysis of a Dendritic Cell Marker Genes Signature to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma

23:41 - 23:42  |  Author(s): Yuan Li

WS08.21 - Immune Evolution of Metastases & Underlying Molecular Mechanisms in Non-small Cell Lung Cancer

23:42 - 23:43  |  Author(s): Wen-Fang Tang

WS08.22 - Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-arm, Phase 2 Trial (Renaissance Study)

23:43 - 23:44  |  Author(s): Shi Yan

WS08.23 - Transcriptomic Heterogeneity in Non-Small Cell Lung Cancer with Four Structure-Based EGFR-Mutation Subgroups

23:44 - 23:45  |  Author(s): LinPing Gu